Equities

Zhejiang Shengda Bio-Pharm Co Ltd

603079:SHH

Zhejiang Shengda Bio-Pharm Co Ltd

Actions
Consumer Staples Food Producers
  • Price (CNY)10.36
  • Today's Change-0.19 / -1.80%
  • Shares traded1.50m
  • 1 Year change-21.99%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments309313510
Total Receivables, Net135144152
Total Inventory228292222
Prepaid expenses2.96149.55
Other current assets, total191725
Total current assets695780919
Property, plant & equipment, net675562580
Goodwill, net111111
Intangibles, net232218156
Long term investments616121
Note receivable - long term------
Other long term assets------
Total assets1,7191,6551,765
LIABILITIES
Accounts payable689272
Accrued expenses343836
Notes payable/short-term debt171125260
Current portion long-term debt/capital leases0.300.590.59
Other current liabilities, total223944
Total current liabilities295295412
Total long term debt1440.300.87
Total debt316126262
Deferred income tax4.288.417.53
Minority interest151516
Other liabilities, total5.467.586.95
Total liabilities465327444
SHAREHOLDERS EQUITY
Common stock171171171
Additional paid-in capital669669669
Retained earnings (accumulated deficit)423488480
Treasury stock - common(8.97)----
Unrealized gain (loss)------
Other equity, total------
Total equity1,2551,3281,320
Total liabilities & shareholders' equity1,7191,6551,765
Total common shares outstanding170171171
Treasury shares - common primary issue0.7200
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.